首页 > 产品目录 > 信号通路 > Cytoskeletal Signaling | 细胞骨架 > Integrin > 依曲利组单抗

依曲利组单抗

ChemLeader 95+%

Etrolizumab (Anti-Integrin α4β7) (ITGA4 & ITGB7)

产品编号：CLA1265 CAS No.：1044758-60-2 MDLNo： 分子式： 分子量：

加入收藏分享给朋友

规格	库存	目录价	会员专享价	数量
1 mg	3-5days	￥6200.00	登录后可见	- +
5 mg	3-5days	￥35600.00	登录后可见	- +
10 mg	3-5days	￥68000.00	登录后可见	- +

化学品安全说明书(MSDS)

下载MSDS

发送询价加入购物车

基本信息
相关文档
产品详情
相关文献

基本信息

英文名称	Etrolizumab (Anti-Integrin α4β7) (ITGA4 & ITGB7)
中文名称	依曲利组单抗
CAS号	1044758-60-2
储存条件	Store at 2 to 8 °C for 1-2 weeks. Store at -20 °C for 12 months. Store at -80 °C for long term storage. Use a manual defrost freezer and avoid repeated freeze-thaw cycles, away from light.

产品详情

Etrolizumab (rhuMAb Beta7) is a gut-selective, anti- β7 integrin monoclonal antibody. Etrolizumab is specific targeting of the β7 subunit of α4β7 and αEβ7 integrins with K i values of 18 nM and 1800 pM for Human α4β7 and Human αEβ7-293, respectively. Etrolizumab can be used in research of inflammatory bowel disease (IBD).